Cardiometabolic Disorders News

Use of AI in medicine is growing quickly. Clinicians are eager to learn what the technology can do, and speakers at meetings across specialties are envisioning its effects — good and bad — in practice management and patient care.

Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.

Intermittent and continuous energy restriction diets both improved cardiometabolic measures and reduced symptoms of depression and disordered eating among adolescents with obesity, according to findings published in JAMA Pediatrics.

Tirzepatide is associated with similar odds for gastrointestinal adverse events and a lower likelihood for diabetic retinopathy and pancreatitis compared with GLP-1 receptor agonists, according to a presenter.

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone improved outcomes compared with placebo regardless of baseline diabetes status, according to new data from the FINEARTS-HF trial.

Adults with type 2 diabetes at high risk for cardiovascular events were more likely to sustain an HbA1c of 6.5% or less at 2 years with tirzepatide if they lost more weight and had improved beta-cell function, according to new data.

High consumption of ultraprocessed food, especially processed meats and sugar-sweetened beverages, was associated with elevated risk for heart disease and stroke, researchers reported.

Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management, a speaker reported.